| 2005 | Doktor bioloških nauka, Biološki fakultet, Univerzitet u Beogradu |
|---|---|
| 1999 | Magistar bioloških nauka Biološki fakultet, Univerzitet u Beogradu |
| 1995 | Diplomirani biolog, Biološki fakultet, Univerzitet u Beogradu |
https://orcid.org/0000-0002-4167-404X
|
| Divac Rankov, A., Kusic-Tisma, J., Ljujic, M., Nikolic, A., Milosevic, K., Vilotijevic Dautovic, G., & Radojkovic, D. (2020). Molecular Diagnostics of Cystic Fibrosis in Serbia: Our Approach to Meet the Diagnostic Challenges. Genetic Testing and Molecular Biomarkers, 24(4), 212–216. https://doi.org/10.1089/gtmb.2019.0171 |
| Novkovic, M., Matic, D., Kusic-Tisma, J., Antonijevic, N., Radojkovic, D., & Rakicevic, L. (2018). Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel. European journal of clinical pharmacology, 74(4), 443–451. https://doi.org/10.1007/s00228-017-2401-5 |
| Backovic, D., Ignjatovic, S., Rakicevic, L., Novkovic, M., Kusic-Tisma, J., Radojkovic, D., ... & Kovac, M. (2016). Clopidogrel high on-treatment platelet reactivity in patients with carotid artery stenosis undergoing endarterectomy. A pilot study. Current Vascular Pharmacology, 14(6), 563–569. https://doi.org/10.2174/1570161114666160714103148 |
| Bačković, D., Ignjatović, S., Rakićević, L., Kusić-Tišma, J., Radojković, D., Čalija, B., ... & Kovač, M. (2016). Influence of Cyp2c19* 2 gene variant on therapeutic response during clopidogrel treatment in patients with carotid artery stenosis. Journal of Medical Biochemistry, 35(1), 1–8. https://doi.org/10.1515/jomb-2015-0009 |
| Rakicevic, L. B., Kusic-Tisma, J. S., Kovac, M. K., Backovic, D. T., & Radojkovic, D. P. (2013). Rationalized DNA sequencing-based protocol for genotyping patients receiving coumarin therapy. Scandinavian Journal of Clinical and Laboratory Investigation, 73(6), 523–527. https://doi.org/10.3109/00365513.2013.809142 |
| 2022–2025 | GENIUS - Genetic and environmental influences on psychological adaptation of children and adults, nosilac projekta Filozofski fakultet u Novom Sadu, finansijer Fond za nauku Republike Srbije u okviru Javnog poziva Programa IDEJE; uloga – rukovodilac radnog paketa |
|---|---|
| 2020– 2022 | Profiling ORC Genetics and Regulation in Cancer, nosilac projekta Institut za molekularnu genetiku i genetičko inženjerstvo, Univerzitet u Beogradu; finansijer Fond za nauku Republike Srbije u okviru Javnog poziva Program saradnje srpske nauke sa dijasporom, uloga - rukovodilac projekta |
| 2020–2021 | A novel genotyping assay for root-knot nematode identification, nosilac projekta Institut za molekularnu genetiku i genetičko inženjerstvo, Univerzitet u Beogradu; finansijer - Inovacioni fond u okviru javnog poziva Dokaz koncepta; uloga - rukovodilac projekta |
|---|---|
| 2013-2016 | Research Potential (REGPOT-2013-1) Strengthening the Research Potential of IMGGE through Reinforcement of Biomedical Science of Rare Diseases in Serbia – en route for innovation, nosilac projekta Institut za molekularnu genetiku i genetičko inženjerstvo, Univerzitet u Beogradu; finansijer Evropska komisija; rukovodilac radnog paketa |
| 2011-2019 | Complex diseases as a model system for phenotype modulation- structural and functional analysis of molecular biomarkers, nosilac projekta Institut za molekularnu genetiku i genetičko inženjerstvo, Univerzitet u Beogradu; finansijer Ministarstvo prosvete Republike Srbije, uloga - učesnik |
| 2009-2011 | Structural alterations of DNA induced by initiator protein, nosilac projekta Institut za molekularnu genetiku i genetičko inženjerstvo, Univerzitet u Beogradu; finansijer ICGEB Research Grants u okviru javnog poziva Collaborative Research Programme, uloga - rukovodilac projekta |
| 2006-2010 | Genome elements in phenotype modulation, nosilac projekta Institut za molekularnu genetiku i genetičko inženjerstvo, Univerzitet u Beogradu; finansijer Ministarstvo prosvete Republike Srbije, uloga - učesnik |